The EU Definition of Nanomaterial – Potential Measurement Methodologies
White Paper Apr 30, 2013
In October 2011 the European Commission published a definition of Nanomaterials. This move followed more than six years of scientific consideration of the potential toxicological and environmental challenges posed by engineered nanomaterials.
The definition has these principal elements:
• Counting particles defines nanomaterials: The material is a nanomaterial if more than 50% of particles have at least one dimension between 1nm and 100nm.
• Alternatively, it is also a nanomaterial if it has a specific surface per unit volume of greater than 60 m2/cm3.
• There are specific inclusions such as graphene.
• Naturally occurring and incidental materials are included, as well as manufactured particles.
• Aggregates and agglomerates of such particles are included.
No measurement methods are specified; the recommendation is ‘best available alternative methods should be applied. This definition is not regulation, however its EU provenance informs its authority. For many regulators within the EU, this definition is the missing jigsaw piece to slot into potential regulation of publically-driven and government-derived legislation, covering nanomaterial matters from manufacture, labelling and handling, through transport and environmental fate. The FP7 project ObservatoryNANO describes current legislative work in their 4th report, April 2012.
Related White Papers
Analysis of Microplastics Using Mobile FTIR and FTIR ImagingWhite Paper
Identifying and quantifying microplastics in wastewater, sediment and fauna.READ MORE
Exploring the Hallmarks of Cancer with Real-time Live-cell AnalysisWhite Paper
The constantly evolving picture of tumor biology is helping to shed new light on the behavior of many cancers, as well as providing new pharmacological targets and treatment strategies.READ MORE
Fully Automated Sensitive Determination of Immunosuppressant Drugs in Whole Blood, using High Quality Internal StandardizationWhite Paper
Measurement of immunosuppressant drugs is essential during organ transplantation. Under-dosing can lead to organ rejection, while over-dosing can cause serious toxicity.READ MORE